The phrase "as peripheral changes" is correct and usable in written English.
It can be used in contexts discussing modifications or alterations that are not central or primary to a subject.
Example: "The study focused on the main factors affecting performance, while also noting the effects of peripheral changes."
Alternatives: "as secondary changes" or "as marginal changes".
Although we assessed platelets of highly valid transgenic animal models of AD and hypercholesterolemia mice with comparable cognitive deficits, none of the currently available models recapitulates all pathological conditions of the human AD brain and they appear limited in mirroring sensitive peripheral changes as seen in the present study.
Moreover, besides neurotransmitters, platelets contain proteins such as APP and produce beta-amyloid and secretases, making them an interesting target to study peripheral changes in AD as they may be useful biomarkers of the disease (Rainesalo et al. 2005; Chen et al. 1995; Li et al. 1999; Evin et al. 2003).
Some researchers insist that the peripheral changes in CRPS must be understood as a manifestation of changes in the brain [ 16].
Physiological conditions such as menopause can interfere with sexual expression because of central and peripheral changes.
The forward was as peripheral as ever through the first period.
To investigate the dynamics of online persuasion, this research uses the Elaboration Likelihood Model (ELM) to determine the effects of argument quality as a central route to influence attitude change versus design and social elements as peripheral routes to attitude change.
Pattern metrics calculated at the patch level are assessed as the spatial organization of landscape units that represent: (1) transitional areas of LULC dynamics occurring as peripheral expansion, (2) LULC change from forest to agriculture through deforestation, or (3) agriculture to forest through secondary plant succession, with savanna serving as a transitional matrix.
Further, self-perception of body changes such as peripheral fat loss or central fat gain are associated with lower adherence [45], and may be more common among those taking PI-based ARVT [46].
Traditionally, treatment outcome has focused on the length of survival and neurological or physiological changes such as peripheral neuropathy, ototoxicity, or encephalopathy rather than indices of 'quality of life', such as neurocognitive function.
12, 13, 15 Most of the patients (60/76) had more than one ADR, and noncumulative changes such as peripheral neuropathy and bone marrow depression were observed, 12, 32 which can be perceived at any time during treatment.
